Evidence map›Paper›PMID 24068891›Full record

ArticlePLoS biology2013

Dectin-1 is essential for reverse transcytosis of glycosylated SIgA-antigen complexes by intestinal M cells.

Nicolas Rochereau, Daniel Drocourt, Eric Perouzel, Vincent Pavot, Pierre Redelinghuys, Gordon D Brown, Gerard Tiraby, Xavier Roblin, Bernard Verrier, Christian Genin and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 174 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. TheCells · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Dectin-1 as a therapeutic target for inflammatory bowel disease.Advances in pharmacology (San Diego, Calif.) · 2024
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Intestinal Peyer's Patches: Structure, Function, and In Vitro Modeling.Tissue engineering and regenerative medicine · 2023
    Review

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Nicolas RochereauGIMAP/EA3064, INSERM CIE3 Vaccinology, Université de Lyon, Saint-Etienne, France.
Daniel Drocourt
Eric Perouzel
Vincent Pavot
Pierre Redelinghuys
Gordon D Brown
Gerard Tiraby
Xavier Roblin
Bernard Verrier
Christian Genin
Blaise Corthésy
Stéphane Paul
Université Claude Bernard Lyon 1 · FRInvivoGen (France) · FRUniversity of Aberdeen · GBUniversity Hospital of Lausanne · CH

Funding

Wellcome Trust 097377
6 · The paper itself

Abstract

Intestinal microfold (M) cells possess a high transcytosis capacity and are able to transport a broad range of materials including particulate antigens, soluble macromolecules, and pathogens from the intestinal lumen to inductive sites of the mucosal immune system. M cells are also the primary pathway for delivery of secretory IgA (SIgA) to the gut-associated lymphoid tissue. However, although the consequences of SIgA uptake by M cells are now well known and described, the mechanisms whereby SIgA is selectively bound and taken up remain poorly understood. Here we first demonstrate that both the Cα1 region and glycosylation, more particularly sialic acid residues, are involved in M cell-mediated reverse transcytosis. Second, we found that SIgA is taken up by M cells via the Dectin-1 receptor, with the possible involvement of Siglec-5 acting as a co-receptor. Third, we establish that transcytosed SIgA is taken up by mucosal CX3CR1⁺ dendritic cells (DCs) via the DC-SIGN receptor. Fourth, we show that mucosal and systemic antibody responses against the HIV p24-SIgA complexes administered orally is strictly dependent on the expression of Dectin-1. Having deciphered the mechanisms leading to specific targeting of SIgA-based Ag complexes paves the way to the use of such a vehicle for mucosal vaccination against various infectious diseases.

Indexed as

AnimalsAntigen-Antibody ComplexAntigens, CDAntigens, Differentiation, MyelomonocyticCaco-2 CellsCell Adhesion MoleculesCell LineCHO CellsCricetulusCX3C Chemokine Receptor 1DC-Specific ICAM-3 Grabbing NonintegrinDectin-1Dendritic CellsGlycosylationHeLa CellsHIV Core Protein p24Antigen-Antibody ComplexAntigens, CDAntigens, Differentiation, MyelomonocyticCell Adhesion MoleculesCX3C Chemokine Receptor 1CX3CR1 protein, humanDC-Specific ICAM-3 Grabbing NonintegrinDectin-1glycosylated IgAHIV Core Protein p24Immunoglobulin AImmunoglobulin A, SecretoryLectinsLectins, C-TypeN-Acetylneuraminic AcidReceptors, Cell SurfaceReceptors, ChemokineSIGLEC5 protein, human

Identifiers

PMID24068891
PMCPMC3775721
OpenAlexW1975414229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.